Cushing's syndrome — imaging localization after biochemical confirmation
Recommended: Pituitary MRI (ACTH-dependent) or adrenal CT (ACTH-independent) is the preferred imaging study for cushing's syndrome — imaging localization after biochemical confirmation. Imaging follows biochemical confirmation (low-dose dexamethasone suppression, midnight cortisol, ACTH).
Pituitary MRI (ACTH-dependent) or adrenal CT (ACTH-independent)
Imaging follows biochemical confirmation (low-dose dexamethasone suppression, midnight cortisol, ACTH). ACTH-dependent (Cushing disease ~70%, ectopic ~10%): dedicated dynamic pituitary MRI with 1 mm sellar protocol. ACTH-independent (~20%): adrenal CT or MRI to characterize adenoma vs carcinoma vs bilateral hyperplasia. Ectopic ACTH: CT chest/abdomen/pelvis + Ga-68 DOTATATE PET-CT for occult source.
If the default doesn't apply
Watch-outs
Up to 10% of adults have an incidental pituitary lesion — biochemistry must precede imaging or you'll over-call.
Most adrenal incidentalomas are non-functional adenomas — don't reverse-engineer Cushing from imaging without biochemistry.
Pearls
- Pituitary microadenoma: dynamic post-contrast sequences improve detection of sub-centimeter lesions.
- Adrenal adenoma washout: absolute > 60% or relative > 40% at 15 min post-contrast.
- DOTATATE PET-CT is the highest-yield study for occult ectopic ACTH source.
- Bilateral adrenal nodular hyperplasia is rare — think McCune-Albright, Carney complex, PPNAD.